Bisphosphonate-associated osteonecrosis of the jaw: The rheumatologist's role

Franco Capsoni, Matteo Longhi, Roberto Weinstein

Research output: Contribution to journalArticlepeer-review


Several recent reports have described osteonecrosis of the jaws (ONJ) associated with the use of bisphosphonates. Rheumatologists treating bone diseases with bisphosphonate need, therefore, to be aware of this potential risk and plan the prophylaxis, early diagnosis and prevention of potential consequences. We review the literature on this newly described complication, with particular focus on systemic and local predisposing pathologies, preventive measures suggested before and during therapy with bisphosphonates, and the most frequent clinical presentation of the oral lesions. The expert panel recommendations for the management of care of patients who develop ONJ are summarized.

Original languageEnglish
Article number219
JournalArthritis Research and Therapy
Issue number5
Publication statusPublished - Oct 2006

ASJC Scopus subject areas

  • Rheumatology
  • Medicine(all)


Dive into the research topics of 'Bisphosphonate-associated osteonecrosis of the jaw: The rheumatologist's role'. Together they form a unique fingerprint.

Cite this